Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Shanghai Kehua Bio-Engineering Co Ltd (002022)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.29 +0.26    +3.70%
02:56:54 - Closed. Currency in CNY ( Disclaimer )
Type:  Equity
Market:  China
ISIN:  CNE000001KC9 
  • Volume: 6,162,450
  • Bid/Ask: 7.29 / 7.29
  • Day's Range: 6.98 - 7.35
Kehua Bio-Engine A 7.29 +0.26 +3.70%

Shanghai Kehua Bio-Engineering Co Ltd Company Profile

 
Get an in-depth profile of Shanghai Kehua Bio-Engineering Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

2709

Equity Type

ORD

Shanghai Kehua Bio-Engineering Co.,Ltd researches and develops, produces, and sells in vitro diagnostic reagents and automatic analyzers in China. It offers signature products, including immunoassay & clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management, and automated comprehensive solutions for nucleic acid blood screening; and immunologic diagnosis products, such as KHB Polaris i1800 full-automatic chemiluminescence immunoassay analysis systems, Polaris i2400 fully automated chemiluminescence immunoassay analysis systems, enzyme linked immunosorbent assay kits, and microplate reader and plate washers. The company also provides biochemical diagnosis products, including ZY Series of automatic clinical chemistry analyzers, Polaris c1000 fully automated modular clinical chemistry analysis systems, and general packaging reagents; and molecular diagnostics products, such as nucleic acid extractors, PCR thermal cyclers, real-time PCR systems, automatic nucleic acid workstations, and compatible kits for extraction and detection; and KHB molecular diagnostics reagents, as well as KHB anti-HIV colloid gold products. It serves hospitals, disease control and prevention centers, blood centers, bio-pharmaceutical enterprises, and scientific research institutions. The company also exports its products. Shanghai Kehua Bio-Engineering Co.,Ltd was founded in 1981 and is headquartered in Shanghai, the People's Republic of China.

Contact Information

Address Caohejing Hi-Tech Park No. 1189 Qinzhou North Road
Xuhui District Shanghai, 200233
China
Phone 86 21 6485 0088
Fax 86 21 6485 4051

Top Executives

Name Age Since Title
Chuanfang Zheng - 2023 Independent Director
Hongying Jin 51 2023 VP, Board Secretary & Non Independent Director
Zhichao Ma 42 2022 Vice Chairman
Jiaming Liang - 2024 Non-Independent Director
Chao Yi - 2023 Non-Employee Supervisor
Zhenxi Zhang - 2024 Independent Director
Niancai Peng - 2024 Non-Independent Director
Ming Li 48 2023 Chairman, President & Director
Lan Xie 54 2022 Non-Employee Supervisor
Baogang Miao - 2024 Non-Independent Director
Ying Li 39 2020 Non-Employee Supervisor
Wenhua Shan - 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

002022 Comments

Write your thoughts about Shanghai Kehua Bio-Engineering Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email